Bazelet Nehushtan LtD.: Clinical Trials

2 trials sponsored by Bazelet Nehushtan LtD., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 1, Unknown 1

Follow Bazelet Nehushtan LtD.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Placebo-Controlled Study of Terpenes-Enriched Cannabis Oil T1/C28 for Children With Autism
Terpenes-Enriched CBD-Predominant Oil, Placebo, Terpenes-Enriched CBD Oil (THC-Free) - Autism, Autism Spectrum Disorder
Phase 2RecruitingBazelet Nehushtan LtD.782025-10-052025-11-19
The Safety and Efficacy of Terpene-enriched Cannabidiol (CBD) Oil in ADHD
Oral CBD oil enriched with terpenes, Oral Placebo - Attention Deficit Hyperactivity Disorder (ADHD)
Phase 2UnknownBazelet Nehushtan LtD.1202024-08-222024-08-23

Conditions studied

Attention Deficit Disorder with Hyperactivity (1)  ·  Autism Spectrum Disorder (1)  ·  Autistic Disorder (1)

Interventions

Terpenes (1)

Countries

Israel (2)

Top investigators

Matitiahu Berkovitch, MD (1)